3Lown J. Administration of Blood Components[M]//Lown J. Transfusion Medicine Blood Transfusion Manual. Perth: Royal Perth Hospital Australia , 2005:14-15. 被引量：1
4VLHSC SJHC. Blood Transfusion Resource Manual [M].London:A Joint Venture of London Health Sciences Centre and St. Joseph's Health Care,2005:19-30. 被引量：1
5Combs M R,Denomme G,Grossman B J, et al. Administration of Blood and Components[M]//AABB.AABB Technical Manual. Bethada: American Association of Blood Banks,2005: 521-534. 被引量：1
6Ritter CA, Arteaga CL. The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors. Semin Oncol, 2003,30(1 Suppl 1):3 11. 被引量：1
7Schiller JH. New directions for ZD1839 in the treatment of solid tumors.Semin Oncol, 2003,30(1 Suppl 1) :49-55. 被引量：1
8Okamoto I, Fujii K, Matsumoto M, et al. Diffuse alveolar damage after ZD1839 therapy in a patient with non-small cell lung cancer. Lung Cancer,2003,40(3):339-342. 被引量：1
9Sirotnak FM. Studies with ZD1839 in preelinical models. Semin Oneol,2003,30 ( 1 Suppl 1) : 12-20. 被引量：1
